Production (Stage)
Wellgistics Health, Inc.
WGRX
$2.36
-$0.12-4.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.86M | 12.41M | 5.67M | -124.00K | 168.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.86M | 12.41M | 5.67M | -124.00K | 168.50K |
| Cost of Revenue | 10.17M | 11.16M | 5.15M | -80.30K | -- |
| Gross Profit | 692.60K | 1.25M | 521.20K | -43.60K | -- |
| SG&A Expenses | 31.24M | 4.35M | 1.80M | 351.90K | 79.80K |
| Depreciation & Amortization | 802.90K | 647.20K | 467.40K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.21M | 16.16M | 7.42M | 271.60K | 79.80K |
| Operating Income | -31.35M | -3.75M | -1.74M | -395.60K | -79.80K |
| Income Before Tax | -32.43M | -4.33M | -1.87M | -400.20K | -83.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.43M | -4.33M | -1.87M | -400.20K | -83.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.43M | -4.33M | -1.87M | -400.20K | -83.10K |
| EBIT | -31.35M | -3.75M | -1.74M | -395.60K | -79.80K |
| EBITDA | -30.52M | -3.01M | -1.38M | -389.20K | -- |
| EPS Basic | -0.62 | -0.09 | -0.04 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.39 | -0.06 | -0.02 | -- | 0.00 |
| EPS Diluted | -0.62 | -0.18 | -0.04 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.39 | -0.06 | -0.02 | -- | 0.00 |
| Average Basic Shares Outstanding | 51.92M | 48.78M | 51.06M | -- | 44.72M |
| Average Diluted Shares Outstanding | 51.92M | 48.78M | 51.06M | 44.72M | 44.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |